149 related articles for article (PubMed ID: 8099121)
1. Parameters affecting the development of non-Hodgkin's lymphoma in patients with severe human immunodeficiency virus infection receiving antiretroviral therapy.
Pluda JM; Venzon DJ; Tosato G; Lietzau J; Wyvill K; Nelson DL; Jaffe ES; Karp JE; Broder S; Yarchoan R
J Clin Oncol; 1993 Jun; 11(6):1099-107. PubMed ID: 8099121
[TBL] [Abstract][Full Text] [Related]
2. Development of non-Hodgkin lymphoma in a cohort of patients with severe human immunodeficiency virus (HIV) infection on long-term antiretroviral therapy.
Pluda JM; Yarchoan R; Jaffe ES; Feuerstein IM; Solomon D; Steinberg SM; Wyvill KM; Raubitschek A; Katz D; Broder S
Ann Intern Med; 1990 Aug; 113(4):276-82. PubMed ID: 1973886
[TBL] [Abstract][Full Text] [Related]
3. Non-Hodgkin's lymphoma in patients with advanced HIV infection treated with zidovudine.
Moore RD; Kessler H; Richman DD; Flexner C; Chaisson RE
JAMA; 1991 May; 265(17):2208-11. PubMed ID: 2013953
[TBL] [Abstract][Full Text] [Related]
4. Opportunistic infection and immunologic function in patients with human immunodeficiency virus-associated non-Hodgkin's lymphoma treated with chemotherapy.
Sparano JA; Hu X; Wiernik PH; Sarta C; Reddy DM; Hanau L; Henry DH
J Natl Cancer Inst; 1997 Feb; 89(4):301-7. PubMed ID: 9048834
[TBL] [Abstract][Full Text] [Related]
5. B-cell stimulation and prolonged immune deficiency are risk factors for non-Hodgkin's lymphoma in people with AIDS.
Grulich AE; Wan X; Law MG; Milliken ST; Lewis CR; Garsia RJ; Gold J; Finlayson RJ; Cooper DA; Kaldor JM
AIDS; 2000 Jan; 14(2):133-40. PubMed ID: 10708283
[TBL] [Abstract][Full Text] [Related]
6. Human immunodeficiency virus infection: personal experience in changes in head and neck manifestations due to recent antiretroviral therapies.
Campanini A; Marani M; Mastroianni A; Cancellieri C; Vicini C
Acta Otorhinolaryngol Ital; 2005 Feb; 25(1):30-5. PubMed ID: 16080313
[TBL] [Abstract][Full Text] [Related]
7. Pilot trial of infusional cyclophosphamide, doxorubicin, and etoposide plus didanosine and filgrastim in patients with human immunodeficiency virus-associated non-Hodgkin's lymphoma.
Sparano JA; Wiernik PH; Hu X; Sarta C; Schwartz EL; Soeiro R; Henry DH; Mason B; Ratech H; Dutcher JP
J Clin Oncol; 1996 Nov; 14(11):3026-35. PubMed ID: 8918501
[TBL] [Abstract][Full Text] [Related]
8. Opportunistic non-Hodgkin's lymphomas among severely immunocompromised HIV-infected patients surviving for prolonged periods on antiretroviral therapy--United States.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1991 Aug; 40(34):591, 597-600. PubMed ID: 1870560
[TBL] [Abstract][Full Text] [Related]
9. CD4 count and the risk for death in patients infected with HIV receiving antiretroviral therapy.
Yarchoan R; Venzon DJ; Pluda JM; Lietzau J; Wyvill KM; Tsiatis AA; Steinberg SM; Broder S
Ann Intern Med; 1991 Aug; 115(3):184-9. PubMed ID: 1676252
[TBL] [Abstract][Full Text] [Related]
10. Clinical aspects of AIDS-related non-Hodgkin's lymphoma.
Northfelt DW; Kaplan LD
Curr Opin Oncol; 1991 Oct; 3(5):872-80. PubMed ID: 1661169
[TBL] [Abstract][Full Text] [Related]
11. Studies of zidovudine in combination with didanosine and zalcitabine.
Jablonowski H
J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S52-6. PubMed ID: 8595509
[TBL] [Abstract][Full Text] [Related]
12. Report on a 3-year follow-up zidovudine (AZT) treatment in a group of HIV-positive patients with congenital clotting disorders.
Sartori MT; Mares M; Zerbinati P; Stocco D; Girolami A
Haematologia (Budap); 1994; 26(1):17-27. PubMed ID: 7959371
[TBL] [Abstract][Full Text] [Related]
13. Zidovudine, didanosine, or both as the initial treatment for symptomatic HIV-infected children. AIDS Clinical Trials Group (ACTG) Study 152 Team.
Englund JA; Baker CJ; Raskino C; McKinney RE; Petrie B; Fowler MG; Pearson D; Gershon A; McSherry GD; Abrams EJ; Schliozberg J; Sullivan JL
N Engl J Med; 1997 Jun; 336(24):1704-12. PubMed ID: 9182213
[TBL] [Abstract][Full Text] [Related]
14. Effect of zidovudine and didanosine treatment on heart function in children infected with human immunodeficiency virus.
Domanski MJ; Sloas MM; Follmann DA; Scalise PP; Tucker EE; Egan D; Pizzo PA
J Pediatr; 1995 Jul; 127(1):137-46. PubMed ID: 7608800
[TBL] [Abstract][Full Text] [Related]
15. Non-Hodgkin's lymphoma in patients with human immunodeficiency virus infection in Taiwan.
Yang CJ; Chen MY; Hsieh SM; Sheng WH; Sun HY; Hung CC; Chang SC
J Microbiol Immunol Infect; 2010 Aug; 43(4):278-84. PubMed ID: 20688287
[TBL] [Abstract][Full Text] [Related]
16. Non-Hodgkin lymphoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy.
Polesel J; Clifford GM; Rickenbach M; Dal Maso L; Battegay M; Bouchardy C; Furrer H; Hasse B; Levi F; Probst-Hensch NM; Schmid P; Franceschi S;
AIDS; 2008 Jan; 22(2):301-6. PubMed ID: 18097233
[TBL] [Abstract][Full Text] [Related]
17. The impact of ethanol and Marinol/marijuana usage on HIV+/AIDS patients undergoing azidothymidine, azidothymidine/dideoxycytidine, or dideoxyinosine therapy.
Whitfield RM; Bechtel LM; Starich GH
Alcohol Clin Exp Res; 1997 Feb; 21(1):122-7. PubMed ID: 9046384
[TBL] [Abstract][Full Text] [Related]
18. L-carnitine reduces lymphocyte apoptosis and oxidant stress in HIV-1-infected subjects treated with zidovudine and didanosine.
Moretti S; Famularo G; Marcellini S; Boschini A; Santini G; Trinchieri V; Lucci L; Alesse E; De Simone C
Antioxid Redox Signal; 2002 Jun; 4(3):391-403. PubMed ID: 12215207
[TBL] [Abstract][Full Text] [Related]
19. Role of serum free light chains in predicting HIV-associated non-Hodgkin lymphoma and Hodgkin's lymphoma and its correlation with antiretroviral therapy.
Bibas M; Trotta MP; Cozzi-Lepri A; Lorenzini P; Pinnetti C; Rizzardini G; Angarano G; Caramello P; Sighinolfi L; Mastroianni CM; Mazzarello G; Di Caro A; Di Giacomo C; d'Arminio Monforte A; Antinori A;
Am J Hematol; 2012 Aug; 87(8):749-53. PubMed ID: 22718364
[TBL] [Abstract][Full Text] [Related]
20. High dose therapy and autologous stem cell transplantation for human immunodeficiency virus-associated non-Hodgkin lymphoma in the era of highly active antiretroviral therapy.
Molina A; Krishnan AY; Nademanee A; Zabner R; Sniecinski I; Zaia J; Forman SJ
Cancer; 2000 Aug; 89(3):680-9. PubMed ID: 10931469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
